Vault-13

TRANSCODE THERAPEUTICS INC

COM NEW · CUSIP 89357L402

0 institutional holders -20 vs Q1 2025
—reported value*
0 new 0 added 0 reduced 20 sold out net sold ≈ $1.1m (-2.1m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

01020Q4 24: 6Q1 25: 20Q2 25: 00Q4 24Q1 25Q2 25
Numbers
QuarterHolders
Q4 20246
Q1 202520
Q2 20250

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q1 25: 18 bought or addedQ1 25: 0 cut or sold outQ1 25Q2 25: 0 bought or addedQ2 25: 20 cut or sold outQ2 25
Numbers
QuarterBought or addedCut or sold out
Q1 2025180
Q2 2025020

Biggest buyers

None

Biggest sellers

Anson Funds Management LP Sold out -1,462,112-1.5m
UBS Group AG Sold out -263,929-263.9k
SABBY MANAGEMENT, LLC Sold out -229,052-229.1k
Warberg Asset Management LLC Sold out -50,000-50.0k
CORSAIR CAPITAL MANAGEMENT, L.P. Sold out -40,000-40.0k
ACADIAN ASSET MANAGEMENT LLC Sold out -22,323-22.3k
COMMONWEALTH EQUITY SERVICES, LLC Sold out -21,674-21.7k
SouthState Bank Corp Sold out -18,010-18.0k
Ground Swell Capital, LLC Sold out -14,363-14.4k
Marex Group Ltd Sold out -12,678-12.7k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
SABBY MANAGEMENT, LLC 13G · passive investor new · filed 2025-01-03 9.9% new 69.6k 2025-01-03
Tracy Thomas Joseph 13D · may seek influence new · filed 2025-03-20
Stated purposeThe original purpose of the transactions that occasioned this filing was an investment by the Reporting Person in the ordinary course of his business and with neither the purpose nor effect of changing or influencing the control of the Issuer, nor in connection with or as a participant in any transaction having such purpose or effect. As of March 10, 2025, however, the Reporting Person determined to initiate discussions with management and the Board of the Issuer concerning ways to create shareholder value through a discussion of an adoption of a more decisive and long-term commercialization and fundraising approach to bring the Issuer's candidate to the market while reducing reliance on short-term higher-cost funding of operations. Such discussions may include a future presentation to the… Full filing
 5.0% new 35.0k 2025-03-20

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change